Patents by Inventor Carl B. Heilman

Carl B. Heilman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Systems and methods for minimally invasive drug delivery to a subarachnoid space
    Patent number: 11850390
    Abstract: Endovascular drug delivery systems and methods are disclosed herein for delivering a therapeutic agent to the intracranial subarachnoid space of a patient, and/or deploying an endovascular drug delivery device distal portion in the intracranial subarachnoid space and a portion of the drug delivery device body in a dural venous sinus such that a therapeutic agent is delivered from the deployed drug delivery device into the intracranial subarachnoid space.
    Type: Grant
    Filed: May 11, 2021
    Date of Patent: December 26, 2023
    Assignee: Cerevasc, Inc.
    Inventors: Adel M. Malek, Carl B. Heilman, David A. Rezac, Jack B. Sattell, Alexander Bonin
  • SYSTEMS AND METHODS FOR MINIMALLY INVASIVE DRUG DELIVERY TO A SUBARACHNOID SPACE
    Publication number: 20210268252
    Abstract: Endovascular drug delivery systems and methods are disclosed herein for delivering a therapeutic agent to the intracranial subarachnoid space of a patient, and/or deploying an endovascular drug delivery device distal portion in the intracranial subarachnoid space and a portion of the drug delivery device body in a dural venous sinus such that a therapeutic agent is delivered from the deployed drug delivery device into the intracranial subarachnoid space.
    Type: Application
    Filed: May 11, 2021
    Publication date: September 2, 2021
    Applicant: CEREVASC, INC.
    Inventors: Adel M. Malek, Carl B. Heilman, David A. Rezac, Jack B. Sattell, Alexander Bonin
  • Systems and methods for minimally invasive drug delivery to a subarachnoid space
    Patent number: 11013900
    Abstract: Endovascular drug delivery systems and methods are disclosed herein for delivering a therapeutic agent to the intracranial subarachnoid space of a patient, and/or deploying an endovascular drug delivery device distal portion in the intracranial subarachnoid space and a portion of the drug delivery device body in a dural venous sinus such that a therapeutic agent is delivered from the deployed drug delivery device into the intracranial subarachnoid space.
    Type: Grant
    Filed: March 8, 2019
    Date of Patent: May 25, 2021
    Assignee: CereVasc, Inc.
    Inventors: Adel M. Malek, Carl B. Heilman, David A. Rezac, Jack B. Sattell, Alexander Bonin
  • SYSTEMS AND METHODS FOR MINIMALLY INVASIVE DRUG DELIVERY TO A SUBARACHNOID SPACE
    Publication number: 20200406018
    Abstract: Endovascular drug delivery systems and methods are disclosed herein for delivering a therapeutic agent to the intracranial subarachnoid space of a patient, and/or deploying an endovascular drug delivery device distal portion in the intracranial subarachnoid space and a portion of the drug delivery device body in a dural venous sinus such that a therapeutic agent is delivered from the deployed drug delivery device into the intracranial subarachnoid space.
    Type: Application
    Filed: March 8, 2019
    Publication date: December 31, 2020
    Applicant: CEREVASC, INC.
    Inventors: Adel M. Malek, Carl B. Heilman, David A. Rezac, Jack B. Sattell, Alexander Bonin